AstraZeneca Keeps Generics Off Shelves Ahead Of Appeal

Counsel for AstraZeneca convinced the Court of Appeal on Monday to review a decision to let rival Glenmark release its generic version of a billion-dollar diabetes treatment under an agreement that...

Already a subscriber? Click here to view full article